^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

TP-0903 is active in models of drug-resistant acute myeloid leukemia

Published date:
12/03/2020
Excerpt:
TP-0903 demonstrated preclinical activity in AML models with FLT3-ITD and common co-occurring mutations in IDH2 and NRAS genes.
DOI:
10.1172/jci.insight.140169